semaglutide injections rye Injectable Weight-Loss and reduced Semaglutide Pens: Do's and Don't

American College of Cardiology Expert Consensus on Obesity Management (ACC, 2024)

By month 4 to 6, patients with tendon and ligament indications have typically moved from pain reduction and mobility improvement to actual strength restoration in the injured structure

Preparing for your consultation : Before your appointment, document: Your weight history, including previous weight loss attempts and outcomes Current medications and medical conditions Perimenopausal symptoms and their impact on daily life Dietary habits and physical activity levels Family history of obesity, diabetes, or thyroid conditions Specific concerns about weight gain and health goals Questions to discuss with your GP : "Am I eligible for referral to specialist weight management services that might consider GLP-1 medications?" "What are the realistic expectations for weight loss with these treatments?" "How would this medication interact with any HRT or other treatments I'm taking?" "What monitoring would be required during treatment?" "What happens when I stop the medicationwill weight return?" "Are there local NHS weight management services that might help?" "Would addressing my perimenopausal symptoms with HRT potentially help with my overall health?" Setting realistic expectations is crucial

GLP-1 receptor analogs, such as exenatide, have a beneficial effect on bone health in women with type 2 diabetes who have gone through menopause (66)

This may be attributed to the fact that all patients had previously tolerated 1.0 mg of semaglutide, suggesting a population with high baseline tolerability to incretin-based treatments